Uchime, Onyinyechukwu
Dai, Zhou
Biris, Nikolaos
Lee, David
Sidhu, Sachdev S.
Li, Sheng
Lai, Jonathan R.
Gavathiotis, Evripidis
Funding for this research was provided by:
National Institutes of Health (R00HL095929)
National Institutes of Health (R01CA178394)
National Institutes of Health (R21CA155472)
National Institutes of Health (R01GM020501)
National Institutes of Health (R56AI110750)
National Institutes of Health (R01AI101436)
National Institutes of Health (T32GM007288)
National Cancer Institute (F31CA186672)
Sidney Kimmel Foundation for Cancer Research
Gabrielle's Angels Foundation for Cancer Research
Alexandrine and Alexander L. Sinsheimer Foundation
This article is maintained by: Elsevier
Article Title: Synthetic Antibodies Inhibit Bcl-2-associated X Protein (BAX) through Blockade of the N-terminal Activation Site
Journal Title: Journal of Biological Chemistry
CrossRef DOI link to publisher maintained version: https://doi.org/10.1074/jbc.M115.680918
Content Type: article
Copyright: © 2016 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.